EFFECTS OF PROTON-PUMP INHIBITORS ON PLATELET AGGREGATION AND LONG-TERM MORTALITY IN OPTIMALLY TREATED STABLE ISCHEMIC HEART DISEASE PATIENTS WITH OR WITHOUT DIABETES MELLITUS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION

The effects of proton-pump inhibitors (PPI) on mortality in stable ischemic heart disease (SIHD) patients (pts) with or without diabetes mellitus (DM) treated with optimal medical therapy (OMT) who undergo elective percutaneous intervention (PCI) have not been well studied. Long-term (70±1 months